Inovio Biomedical Corporation (AMEX: INO), a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has initiated a Phase I clinical trial to treat locally recurrent cancer after a mastectomy or partial mastectomy using its Selective Electrochemical Tumor Ablation (SECTA) therapy.

Read Story...

Buy Perfumes & Colognes
Sonia Rykiel Rykiel Homme Grey 4.2 oz EDT Spray (Tester)
perfumes
Austin Croshere Posters